A global consortium of researchers has pioneered an innovative technology capable of detecting or potentially treating cancer within challenging-to-access regions like the colon. The team’s breakthrough technique, labelled CATCH (cellular assay for targeted, CRISPR-discriminated horizontal gene transfer), has been documented in a Science paper.
Read: vivo v27e Review: Beautifully disappointing
In this week’s Tech Tuesday segment on Smile 90.4FM we discuss how genetic engineering in bacteria is being used to detect cancer.
Listen down below.
